Medigene AG Medigene AG

Medigene AG

MDG1

Rang în acțiuni #35296
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Preț acțiune
$0.14942078
Ultima sincronizare: 2025-05-15
Capitalizare de piață
$3.86M
Schimbare (1 zi)
0.10%
Schimbare (1 an)
47.84%
Țară
DE
Tranzacționează Medigene AG (MDG1)

Categorie

Healthcare
Istoricul spliturilor pentru Medigene AG (MDG1)
Acțiunea Medigene AG (simbol: MDG1) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 21, 2026.
O acțiune MDG1 cumpărată înainte de Oct 21, 2026 este echivalentă astăzi cu 0 acțiuni MDG1.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH